IPERLIPOPROTEINEMIE E DIABETE = HYPERLIPOPROTEINEMIES ET DIABETECREPALDI G; TIENGO A.1976; MINERVA, MED.; ITAL.; DA. 1976; VOL. 67; NO 4; PP. 290-300; BIBL. 48 REF.Article

CLINICAL ASPECTS OF HYPERLIPOPROTEINEMIACREPALDI G; FELLIN R.1974; ANN. BIOL. CLIN.; FR.; DA. 1974; VOL. 32; NO 4; PP. 309-322; BIBL. 37REF.Article

THE INFLUENCE OF PLASMA TRIGLYCERIDES ON HUMAN GROWTH HORMONE RESPONSE TO ARGININE AND INSULIN: A STUDY IN HYPERLIPEMICS AND NORMAL SUBJECTS. = INFLUENCE DES TRIGLYCERIDES PLASMATIQUES SUR LA REPONSE DE L'HORMONE SOMATOTROPE HUMAINE A L'ARGININE ET L'INSULINE: ETUDE CHEZ DES SUJETS HYPERLIPEMIQUES ET NORMAUXMUGGEO M; TIENGO A; FEDELE D et al.1975; HORMONE METABOL. RES.; GERM.; DA. 1975; VOL. 7; NO 5; PP. 367-374; BIBL. 1 P.Article

GROWTH HORMONE SECRETION IN PRIMARY ENDOGENOUS HYPERTRIGLYCERIDEMIA = SECRETION D'HORMONE SOMATOTROPE DANS L'HYPERTRIGLYCERIDEMIE PRIMAIRE ENDOGENEMUGGEO M; FEDELE D; TIENGO A et al.1973; HORMONE METABOL. RES.; GERM.; DA. 1973; VOL. 5; NO 3; PP. 224-225; BIBL. 5 REF.Article

Minibus électrique pour le centre historique de Trento = Electric minibus for Trento's historic centerCREPALDI, G.Véhicule électrique. Colloque. 1991, 15 p.Conference Paper

EFFECT OF PITUITARY ULTRASONIC TREATMENT ON PLASMA HUMAN GROWTH HORMONE LEVELS IN DIABETIC RETINOPATHY AND ACROMEGALY. = EFFET DU TRAITEMENT DE L'HYPOPHYSE PAR ULTRASONS SUR LE TAUX PLASMATIQUE D'HORMONE DE CROISSANCE DANS LA RETINOPATHIE DIABETIQUE ET L'ACROMEGALIE HUMAINEMUGGEO M; MOLINARI M; FEDELE D et al.1976; ACTA DIABETOL. LATINA; ITAL.; DA. 1976; VOL. 12; NO 2; PP. 137-149; BIBL. 1 P. 1/2Article

GLUCAGON SECRETION IN PRIMARY ENDOGENOUS HYPERTRIGLYCERIDEMIA BEFORE AND AFTER CLOFIBRATE TREATMENT. = SECRETION DE GLUCAGON DANS L'HYPERTRIGLYCERIDEMIE ENDOGENE PRIMAIRE AVANT ET APRES TRAITEMENT PAR CLOFIBRATETIENGO A; MUGGEO M; ASSAN R et al.1975; METABOLISM; U.S.A.; DA. 1975; VOL. 24; NO 8; PP. 901-914; BIBL. 1 P.Article

TERAPIA DELLE IPERLIPOPROTEINEMIE = THERAPEUTIQUE DES HYPERLIPOPROTEINEMIESCREPALDI G; FELLIN R; BRIANI G et al.1974; G. ITAL. CARDIOL.; ITAL.; DA. 1974; VOL. 4; NO 3; PP. 332-340; ABS. ANGL.; BIBL. 27 REF.Article

TRATTAMENTO DELLE IPERLIPIDEMIE PRIMITIVE CON UN TETRALIN-DERIVATO = TRAITEMENT DES HYPERLIPIDEMIES PRIMITIVES AU MOYEN D'UN DERIVE DE TETRALINEFELLIN R; FEDELE D; BAGNARIOL G et al.1972; G. ITAL. CARDIOL.; ITAL.; DA. 1972; VOL. 2; NO 6A; PP. 863-870; ABS. ANGL.; BIBL. 14 REF.Serial Issue

TRYPTOPHAN METABOLISM "VIA" NICOTINIC ACID IN PATIENTS WITH SCLERODERMA.DE ANTONI A; MUGGEO M; COSTA C et al.1976; ACTA VITAMINOL. ENZYMOL.; ITAL.; DA. 1976; VOL. 30; NO 4-6; PP. 134-139; ABS. ITAL.; BIBL. 14 REF.Article

PROCEEDINGS/OBESITY; PATHOGENESIS AND TREATMENT, SERONO SYMPOSIUM, ROME, JANUARY 1980ENZI G ED; CREPALDI G ED; POZZA G ED et al.1981; OBESITY: PATHOGENESIS AND TREATMENT. SYMPOSIUM/1980-01/ROME; GBR/USA/CAN; LONDON; NEW YORK; TORONTO: ACADEMIC PRESS; DA. 1981; 347 P.; 24 CM; ISBN 0-12-240150-6; PROCEEDINGS OF THE SERONO SYMPOSIA; 28Conference Proceedings

EFFECTS OF CLOFIBRATE TREATMENT ON ARGININE-INDUCED INSULIN SECRETION IN ENDOGENOUS HYPERTRIGLYCERIDEMIA.FEDELE D; TIENGO A; MUGGEO M et al.1976; ATHEROSCLEROSIS; NETHERL.; DA. 1976; VOL. 25; NO 2-3; PP. 191-198; BIBL. 1 P.Article

SHORT-TERM AND LONG-TERM CLINICAL EVALUATION OF A NON-AMPHETAMINE ANOREXIANT (MAZINDOL) IN THE TREATMENT OF OBESITY.ENZI G; BARITUSSIO A; MARCHIORI E et al.1976; J. INTERNATION. MED. RES.; G.B.; DA. 1976; VOL. 4; NO 5; PP. 305-318; BIBL. 20 REF.Article

Dyslipoproteinemia in manifest diabetesMANZATO, E; CREPALDI, G.Journal of internal medicine. Supplement. 1994, Vol 236, Num 736, pp 27-31, issn 0955-7873Article

LONG-TERM TRIAL WITH COLESTIPOL PLUS CLOFIBRATE IN FAMILIAL HYPERCHOLESTEROLEMIA.FELLIN R; BAGGIO G; BRIANI G et al.1978; ATHEROSCLEROSIS; NETHERL.; DA. 1978; VOL. 29; NO 2; PP. 241-249; BIBL. 1 P. 1/2Article

What therapy do our NIDDM patients need ? Insulin releasersCREPALDI, G; DEL PRATO, S.Diabetes research and clinical practice. 1995, Vol 28, Num AOU, pp S159-S165, issn 0168-8227, SUPConference Paper

Comparison of lipoprotein(a) assay methods in serum and in a plasminogen-free fractionBALDO-ENZI, G; BAIOCCHI, M. R; CREPALDI, G et al.Clinica chimica acta. 1993, Vol 218, Num 1, pp 83-95, issn 0009-8981Article

LONG-TERM EFFECTS OF COLESTIPOL (U-26,597 A) ON PLASMA LIPIDS IN FAMILIAL TYPE II HYPERBETALIPOPROTEINAEMIA. = EFFETS A LONG TERME DU COLESTIPOL (U-26597 A) SUR LES LIPIDES DU PLASMA DANS L'HYPERBETALIPOPROTEINEMIE TYPE II FAMILIALEFELLIN R; BRIANI G; BALESTRIERI P et al.1975; ATHEROSCLEROSE; NETHERL.; DA. 1975; VOL. 22; NO 3; PP. 431-445; BIBL. 1 P.Article

Glycosaminoglycans delay the progression of nephropathy in NIDDMSOLINI, A; VERGNANI, L; RICCI, F et al.Diabetes care. 1997, Vol 20, Num 5, pp 819-823, issn 0149-5992Article

Therapy with glycosaminoglycans lowers albumin excretion rate in non-insulin dependent diabetic patients with macroalbuminuriaSOLINI, A; CARRARO, A; BARZON, I et al.Diabetes, nutrition & metabolism (Testo stampato). 1994, Vol 7, Num 5, pp 304-307, issn 0394-3402Article

Plurimetabolic syndrome or syndrome X: is it a real syndrome?CREPALDI, G; MANZATO, E; NOSADINI, R et al.Frontiers in diabetes. 1993, Vol 12, pp 152-164, issn 0251-5342Article

Epidemiology of osteoporosis : a study of fracture mortality in ItalyHEYSE, S. P; SARTORI, L; CREPALDI, G et al.Calcified tissue international. 1990, Vol 46, Num 5, pp 289-293, issn 0171-967X, 5 p.Article

INSULIN RECEPTOR ON MONOCYTES FROM PATIENTS WITH ACROMEGALY AND FASTING HYPERGLYCEMIAMUGGEO M; SAVIOLAKIS GA; BUSINARO V et al.1983; JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM; ISSN 0021-972X; USA; DA. 1983; VOL. 56; NO 4; PP. 733-738; BIBL. 14 REF.Article

OSTEOPOROSIS AMONG ITALIAN WOMEN AT RISK: THE OSTEOLAB STUDYNOALE, M; MAGGI, S; CREPALDI, G et al.The Journal of nutrition, health & aging. 2012, Vol 16, Num 6, pp 529-533, issn 1279-7707, 5 p.Article

Cytokine levels in osteoarthrosis patients undergoing mud bath therapyBELLOMETTI, S; GIANNINI, S; SARTORI, L et al.International journal of clinical pharmacology research. 1997, Vol 17, Num 4, pp 149-153, issn 0251-1649Article